Clinical TrialID 1901

Ginsenoside-Rd for Acute Ischemic Stroke

NCT00591084

Ischemic Stroke

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final clinical_trial record.

Clinical Trial Id
1901
Evidence Id
1901
Core Evidence Id
1901
Source Clinical Trial Id
2485
Herb2 Clinical Trial Id
HBCT002485
Nct Id
NCT00591084
Title
Ginsenoside-Rd for Acute Ischemic Stroke
Status
Completed
Phase
Phase 2
Study Result
No
Study Condition
Ischemic Stroke
Study Type
Interventional
Study Design
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Intervention
DRUG: ginsenoside-Rd 10 mg|DRUG: placebo|DRUG: ginsenoside-Rd 20mg
Intervention Allocation
Randomized
Intervention Model
Parallel
Intervention Mask
Double
Intervention Purpose
Treatment
Gender
All
Age
Adult, Older_Adult
Enrollment
199
Outcome Measure
NIHSS scores, 15±1 days
Sponsor Collaborator
Xijing Hospital
Funded By
OTHER
Location
the Department of Neurology , Xijing Hospital, Xi'an, Shaanxi, 710032, China
Other Id
xijing-001
Start Date
2005-09
Primary Completion Date
2006-06
Completion Date
2006-09
First Posted
2008-01-11
Results First Posted
Last Update Posted
2010-09-01
Study Document
Study Url
https://clinicaltrials.gov/study/NCT00591084
Title Cn
Title En
Ginsenoside-Rd for Acute Ischemic Stroke
Bilingual Status
semi_complete